Variant report
Variant | esv275195 |
---|---|
Chromosome Location | chr4:131390367-131399503 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs5001529 | chr4:131390367-131390368 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs542037231 | chr4:131390369-131390370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571740840 | chr4:131390438-131390439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191320588 | chr4:131390460-131390461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs557306929 | chr4:131390468-131390469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs149777032 | chr4:131390510-131390511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530736758 | chr4:131390593-131390594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375001826 | chr4:131390621-131390622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148621550 | chr4:131390647-131390648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556401589 | chr4:131390656-131390657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142050846 | chr4:131390668-131390669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4320147 | chr4:131390681-131390682 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs4303994 | chr4:131390704-131390705 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs375028399 | chr4:131390712-131390713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558064411 | chr4:131390743-131390744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4504274 | chr4:131390761-131390762 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs146701814 | chr4:131390787-131390788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576510835 | chr4:131390791-131390792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544011078 | chr4:131390829-131390830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540490026 | chr4:131390852-131390853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs562495543 | chr4:131390869-131390870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs529703743 | chr4:131390899-131390900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560289291 | chr4:131390947-131390948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs202063141 | chr4:131390950-131390951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561530188 | chr4:131390978-131390979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528814671 | chr4:131390996-131390997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10020348 | chr4:131390997-131390998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs10028653 | chr4:131399048-131399049 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs75005827 | chr4:131399051-131399052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529056378 | chr4:131399052-131399053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111516019 | chr4:131399070-131399071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532914662 | chr4:131399090-131399091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530159479 | chr4:131399139-131399140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs551341778 | chr4:131399143-131399144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34935548 | chr4:131399208-131399209 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs538148467 | chr4:131399221-131399222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs78562939 | chr4:131399232-131399233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs550017058 | chr4:131399233-131399234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568425981 | chr4:131399256-131399257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62318214 | chr4:131399376-131399377 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs554097679 | chr4:131399379-131399380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs75967942 | chr4:131399383-131399384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35657782 | chr4:131399389-131399390 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs558128988 | chr4:131399421-131399422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77643039 | chr4:131399431-131399432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190549049 | chr4:131399447-131399448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs561928822 | chr4:131399449-131399450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574006426 | chr4:131399462-131399463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112422478 | chr4:131399477-131399478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Mental retardation | 17847001 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Mental retardation | 17901693 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:131389800-131390800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr4:131390800-131391000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr4:131399000-131401000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:131399000-131401000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr4:131399400-131399800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr4:131399400-131399800 | Enhancers | NHLF | lung |
7 | chr4:131399400-131400000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:131399400-131400000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr4:131399400-131400800 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr4:131399400-131400800 | Enhancers | HMEC | breast |